- Home
- CRBP vs BZFD Comparison
CRBP vs BZFD Comparison
Compare CRBP & BZFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- BZFD
- Stock Information
- Founded
- CRBP 2009
- BZFD 2006
- Country
- CRBP United States
- BZFD United States
- Employees
- CRBP N/A
- BZFD N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- BZFD Movies/Entertainment
- Sector
- CRBP Health Care
- BZFD Consumer Discretionary
- Exchange
- CRBP Nasdaq
- BZFD Nasdaq
- Market Cap
- CRBP 73.4M
- BZFD 77.5M
- IPO Year
- CRBP N/A
- BZFD N/A
- Fundamental
- Price
- CRBP $5.31
- BZFD $2.13
- Analyst Decision
- CRBP Strong Buy
- BZFD
- Analyst Count
- CRBP 10
- BZFD 0
- Target Price
- CRBP $60.89
- BZFD N/A
- AVG Volume (30 Days)
- CRBP 213.2K
- BZFD 435.7K
- Earning Date
- CRBP 03-11-2025
- BZFD 03-13-2025
- Dividend Yield
- CRBP N/A
- BZFD N/A
- EPS Growth
- CRBP N/A
- BZFD N/A
- EPS
- CRBP N/A
- BZFD N/A
- Revenue
- CRBP N/A
- BZFD $189,887,000.00
- Revenue This Year
- CRBP N/A
- BZFD $89.62
- Revenue Next Year
- CRBP $270.01
- BZFD $4.50
- P/E Ratio
- CRBP N/A
- BZFD N/A
- Revenue Growth
- CRBP N/A
- BZFD N/A
- 52 Week Low
- CRBP $5.12
- BZFD $1.26
- 52 Week High
- CRBP $61.90
- BZFD $5.68
- Technical
- Relative Strength Index (RSI)
- CRBP 27.45
- BZFD 46.85
- Support Level
- CRBP $5.76
- BZFD $2.12
- Resistance Level
- CRBP $6.17
- BZFD $2.48
- Average True Range (ATR)
- CRBP 0.39
- BZFD 0.14
- MACD
- CRBP 0.03
- BZFD 0.03
- Stochastic Oscillator
- CRBP 9.73
- BZFD 42.11
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.